Legacy Financial Advisors Inc. Takes $142,000 Position in Select Medical Holdings Co. (SEM)

Share on StockTwits

Legacy Financial Advisors Inc. bought a new stake in shares of Select Medical Holdings Co. (NYSE:SEM) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 7,761 shares of the health services provider’s stock, valued at approximately $142,000.

Several other large investors have also made changes to their positions in SEM. Itau Unibanco Holding S.A. purchased a new position in Select Medical in the 2nd quarter valued at $120,000. UBS Group AG lifted its holdings in Select Medical by 2,189.3% in the 1st quarter. UBS Group AG now owns 7,738 shares of the health services provider’s stock valued at $133,000 after purchasing an additional 7,400 shares in the last quarter. Mount Yale Investment Advisors LLC purchased a new position in Select Medical in the 1st quarter valued at $136,000. Public Employees Retirement Association of Colorado lifted its holdings in Select Medical by 232.4% in the 3rd quarter. Public Employees Retirement Association of Colorado now owns 11,155 shares of the health services provider’s stock valued at $205,000 after purchasing an additional 7,799 shares in the last quarter. Finally, Bank of Montreal Can lifted its holdings in Select Medical by 237.3% in the 3rd quarter. Bank of Montreal Can now owns 11,483 shares of the health services provider’s stock valued at $212,000 after purchasing an additional 8,079 shares in the last quarter. Hedge funds and other institutional investors own 74.47% of the company’s stock.

Shares of NYSE SEM traded down $0.01 during trading on Tuesday, hitting $16.57. 146,562 shares of the company were exchanged, compared to its average volume of 585,778. Select Medical Holdings Co. has a 12-month low of $15.83 and a 12-month high of $21.65. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 3.35. The firm has a market cap of $2.19 billion, a PE ratio of 17.08, a P/E/G ratio of 1.13 and a beta of 1.37.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, August 2nd. The health services provider reported $0.31 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.05). Select Medical had a return on equity of 16.90% and a net margin of 4.17%. The company had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter in the prior year, the firm earned $0.32 EPS. The firm’s revenue was up 15.6% on a year-over-year basis. Research analysts expect that Select Medical Holdings Co. will post 1.02 EPS for the current year.

A number of brokerages have weighed in on SEM. Zacks Investment Research lowered Select Medical from a “hold” rating to a “sell” rating in a report on Tuesday, August 7th. ValuEngine lowered Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, September 12th. Finally, Credit Suisse Group assumed coverage on Select Medical in a report on Tuesday, October 16th. They set a “neutral” rating and a $18.00 price target on the stock. Five analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $20.57.

In related news, Chairman Robert A. Ortenzio sold 11,923 shares of the firm’s stock in a transaction dated Thursday, August 30th. The stock was sold at an average price of $20.00, for a total transaction of $238,460.00. Following the completion of the sale, the chairman now directly owns 7,000,171 shares of the company’s stock, valued at approximately $140,003,420. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Robert A. Ortenzio sold 10,402 shares of the firm’s stock in a transaction dated Tuesday, August 7th. The stock was sold at an average price of $20.16, for a total value of $209,704.32. Following the sale, the chairman now directly owns 7,012,094 shares of the company’s stock, valued at $141,363,815.04. The disclosure for this sale can be found here. Insiders have sold a total of 103,434 shares of company stock valued at $2,081,272 over the last three months. Corporate insiders own 19.86% of the company’s stock.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.

Further Reading: Do Tariffs Work?

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply